Celltrion outlines a blueprint for innovative drug development built on its antibody expertiseThe company highlights its ...

Therapies that target the utilization of fat by tumors and activate a type of cell death dependent on fat molecules may be a ...

Our results provide mechanistic evidence that immune responses to EBV can directly damage the brain in MS,” said Olivia Thomas, PhD, assistant professor at the Department of Clinical Neuroscience at ...

Researchers identify two key proteins that allow chandelier cells to connect with excitatory neurons. This "handshake" regulates brain signals and, when disrupted, may lead to epilepsy or autism.

The result is one molecule that can be both a checkpoint degrader and a cancer vaccine ( Nature 2026, DOI: 10.1038/s41586-025 ...

Bloom Energy Corporation (NYSE: BE) is one of the AI Stocks Investors Are Watching Closely. On January 9, BMO Capital analyst ...

MoneyShow presents top investment ideas for 2026 from leading advisors. Part 1 includes Ceragon Networks, Celldex, ...

Inhibrx Biosciences, Inc. stays a Strong Buy with Q2 2026 ozekibart BLA catalyst, 2026 PFS data, and Ewing sarcoma updates.

These four quality stocks from the Raymond James Best Picks list for 2026 offer investors solid dividends and strong upside ...

Autoimmune diseases such as multiple sclerosis arise when the immune system turns against the body itself. Yet for most of ...

In silico antibody accessibility analysis indicates that ectodomain epitopes are transiently exposed, while MPER epitopes are virtually always occluded in the pre-fusion trimer.

New research reveals how a class of neurons that help coordinate communication in the brain link up with their target cells, ...